ID26317A - Formulasi pelepasan yang diperpanjang - Google Patents

Formulasi pelepasan yang diperpanjang

Info

Publication number
ID26317A
ID26317A IDW20000834A ID20000834A ID26317A ID 26317 A ID26317 A ID 26317A ID W20000834 A IDW20000834 A ID W20000834A ID 20000834 A ID20000834 A ID 20000834A ID 26317 A ID26317 A ID 26317A
Authority
ID
Indonesia
Prior art keywords
extended formulation
formulation
extended
Prior art date
Application number
IDW20000834A
Other languages
English (en)
Indonesian (id)
Inventor
Deborah Marie Sherman
John Clifton Clark
John Ulrick Lamer
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID26317(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of ID26317A publication Critical patent/ID26317A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20000834A 1997-11-05 1998-11-03 Formulasi pelepasan yang diperpanjang ID26317A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05

Publications (1)

Publication Number Publication Date
ID26317A true ID26317A (id) 2000-12-14

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000834A ID26317A (id) 1997-11-05 1998-11-03 Formulasi pelepasan yang diperpanjang

Country Status (39)

Country Link
EP (1) EP1028718B1 (es)
JP (1) JP2001521892A (es)
KR (1) KR20010031797A (es)
CN (1) CN1278165A (es)
AR (1) AR014012A1 (es)
AT (1) ATE237320T1 (es)
AU (1) AU747978B2 (es)
BG (1) BG104397A (es)
BR (1) BR9813179A (es)
CA (1) CA2305242A1 (es)
CL (1) CL2004001705A1 (es)
CO (1) CO5011060A1 (es)
CZ (1) CZ20001659A3 (es)
DE (1) DE69813602T2 (es)
DK (1) DK1028718T3 (es)
EA (1) EA200000487A1 (es)
EE (1) EE04577B1 (es)
ES (1) ES2196620T3 (es)
GE (1) GEP20043198B (es)
HK (1) HK1029056A1 (es)
HR (1) HRP20000213B1 (es)
HU (1) HU225238B1 (es)
ID (1) ID26317A (es)
IL (1) IL135457A0 (es)
MA (1) MA24691A1 (es)
NO (1) NO20002126L (es)
NZ (1) NZ504460A (es)
PA (1) PA8462501A1 (es)
PE (1) PE128699A1 (es)
PL (1) PL341141A1 (es)
PT (1) PT1028718E (es)
SK (1) SK6472000A3 (es)
SV (1) SV1998000131A (es)
TR (1) TR200001232T2 (es)
TW (1) TW555568B (es)
UA (1) UA77145C2 (es)
UY (2) UY25234A1 (es)
WO (1) WO1999022724A2 (es)
ZA (1) ZA9810081B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059851A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
MXPA04005305A (es) * 2001-12-05 2004-09-13 Wyeth Corp Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
ATE336988T1 (de) * 2003-07-30 2006-09-15 Pharmathen Sa Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
SI1711169T1 (sl) 2004-02-04 2007-10-31 Alembic Ltd Obložene minitablete venlafaksin hidroklorida s podaljšanim sproščanjem
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
NZ504460A (en) 2003-01-31
AU747978B2 (en) 2002-05-30
PT1028718E (pt) 2003-07-31
HK1029056A1 (en) 2001-03-23
GEP20043198B (en) 2004-03-25
WO1999022724A2 (en) 1999-05-14
CA2305242A1 (en) 1999-05-14
PA8462501A1 (es) 2000-05-24
MA24691A1 (fr) 1999-07-01
HUP0004287A2 (hu) 2002-04-29
JP2001521892A (ja) 2001-11-13
EP1028718B1 (en) 2003-04-16
EP1028718A2 (en) 2000-08-23
UY25234A1 (es) 2000-12-29
NO20002126D0 (no) 2000-04-26
EE04577B1 (et) 2006-02-15
ES2196620T3 (es) 2003-12-16
PL341141A1 (en) 2001-03-26
ATE237320T1 (de) 2003-05-15
TR200001232T2 (tr) 2000-12-21
BG104397A (en) 2001-02-28
SV1998000131A (es) 1999-11-18
BR9813179A (pt) 2000-08-22
UA77145C2 (en) 2006-11-15
HRP20000213A2 (en) 2000-12-31
DK1028718T3 (da) 2003-07-28
CL2004001705A1 (es) 2005-06-03
UY25692A1 (es) 2000-03-31
DE69813602T2 (de) 2003-11-06
PE128699A1 (es) 2000-01-06
DE69813602D1 (de) 2003-05-22
CZ20001659A3 (cs) 2001-10-17
CN1278165A (zh) 2000-12-27
HRP20000213B1 (en) 2004-04-30
IL135457A0 (en) 2001-05-20
EE200000212A (et) 2001-04-16
SK6472000A3 (en) 2000-11-07
CO5011060A1 (es) 2001-02-28
TW555568B (en) 2003-10-01
KR20010031797A (ko) 2001-04-16
HU225238B1 (en) 2006-08-28
WO1999022724A3 (en) 1999-07-22
EA200000487A1 (ru) 2000-10-30
HUP0004287A3 (en) 2002-05-28
AU1300399A (en) 1999-05-24
ZA9810081B (en) 2000-05-04
NO20002126L (no) 2000-05-04
AR014012A1 (es) 2001-01-31

Similar Documents

Publication Publication Date Title
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID22939A (id) Formulasi-formulasi farmasi yang mengandung vorikonozal
DE69817706D1 (de) UV-Schutzformulierung
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
PT1006792E (pt) Formulacao agroquimica
MA24473A1 (fr) Formulations
ID26334A (id) Morfolinol yang aktif secara farmasi
ID29635A (id) Formulasi mikrokapsul
ID28698A (id) Formulasi antiparasit
IS5393A (is) Ný froðumyndandi lyfjablanda
DE69833739D1 (de) Kosmetisches Präparat
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
ID26330A (id) Polipeptida-polipeptida yang bergantung vitamin k yang dimodifikasi
ID24654A (id) Formulasi farmasi omeprazola
ID26317A (id) Formulasi pelepasan yang diperpanjang
PT996418E (pt) Composicoes dermatologicas
ID27655A (id) Formulasi mikrokapsul
ID24716A (id) Formulasi baru
ID24431A (id) Lateks-lateks yang tahan gosokan
ID23928A (id) Formulasi mengandung insektisida
EE9900594A (et) Uued astmavastased ravimkoostised
NO20002555D0 (no) Skjøt
ID23429A (id) Komposisi-komposisi sertralina yang larut
ATE268607T1 (de) Allergenformulierung